Which Breast Cancer Treatment Should You Choose? at www.ResourcesForBreastCancer.com
ResourcesForBreastCancer.com :: Walk to beat breast cancer

Walk to beat breast cancer


WOMEN with breast cancer who walk at least an hour a week have a better chance of beating the disease than those who don't exercise at all, researchers said. "It is well established that exercise plays an important role in preventing many diseases, including breast cancer," said lead researcher Michelle Holmes of Brigham and Women's Hospital in Boston.

"However, we found that women who are physically active after breast cancer diagnosis may lower their risk of death from breast cancer and cancer recurrence." Even walking an hour a week lifted survival rates but exercising more than five hours a week did not confer any added survival benefit. The study noted discouraging estimates that women with breast cancer tend to decrease their levels of physical activity by two hours a week and those whoa re obese reduce activity even more.

About the Author

www.medical-explorer.com

Written by: Anonymous

Updates and Recent News

New Drug For Breast Cancer
A tamoxifen-like drug developed by UC Davis and Finnish scientists, now in clinical testing as a treatment for vaginal atrophy, may also help to prevent breast cancer, two preliminary studies suggest. ..
To Read More...

Fenretinide Cuts The Risk Of Second Breast Cancers
A 15-year follow-up of women in a breast cancer trial has found that fenretinide[1] - a drug correlation to vitamin A - significantly cuts the risk of a second breast cancer among younger patients. The Italian research team reporting the findings on-line (Thursday 4 May) in Annals of Oncology[2], are sufficiently convinced of the drug's protective potential to call for a trial to test its use as a preventive in pre-menopausal healthy women at high risk of the disease. They are now seeking international partners and funding for such a trial....
To Read More...

Targeting Protein S14 In Breast Cancer Treatment
William Kinlaw, an associate professor of medicine at Dartmouth Medical School, has been working on a protein called S14 since 1990. Over the past few months, however, the news about S14 has picked up. Through a series of recently published academic studies, Kinlaw and colleagues are ready to pronounce S14 a potential drug target in treating breast cancer....
To Read More...